论文部分内容阅读
目的探讨中西药联合治疗慢性盆腔炎(CPID)临床效果。方法 150例符合慢性盆腔炎中医辨证患者随机分为3组:中药治疗组(30人),西药治疗组(30人)和联合治疗组(90人),西药治疗组服用甲磺酸帕珠沙星,中药治疗组根据症型服用方剂,联合治疗组用药为中西药联合。结果 CPID患者中联合治疗组患者治疗总有效率明显高于其他2组,疗程结束后症状改善情况也优于单药治疗组。CPID患者复发率及受孕率较西药治疗组、中药治疗组都有改善。结论中西医结合治疗CPID提高疗效,改善症状,且复发率低,并能提高不孕患者的受孕率。
Objective To explore the clinical effect of combining traditional Chinese and western medicine on chronic pelvic inflammatory disease (CPID). Methods 150 cases of patients with chronic pelvic inflammatory disease were randomly divided into three groups: Chinese medicine treatment group (30), Western medicine treatment group (30) and combination therapy group (90), Western medicine treatment group taking Pazoside mesylate Star, traditional Chinese medicine treatment group according to Symptoms taking prescriptions, combination therapy group for the combination of Chinese and Western medicine. Results The total effective rate of patients in combination therapy group was significantly higher than that of the other two groups in CPID patients. After the treatment, the symptom improvement was better than monotherapy group. CPID patients relapse rate and pregnancy rate than Western medicine group, Chinese medicine treatment group have improved. Conclusion The combination of TCM and Western medicine treatment of CPID improve efficacy, improve symptoms, and the recurrence rate is low, and can improve the pregnancy rate of infertility patients.